Haverford, PA, United States of America

Ramana V Davuluri

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ramana V Davuluri

Introduction

Ramana V Davuluri is a notable inventor based in Haverford, Pennsylvania. He has made significant contributions to the field of medical diagnostics, particularly in the classification of glioblastoma subtypes. His work is characterized by a focus on precision and accuracy in cancer diagnosis.

Latest Patents

Davuluri holds a patent for "Methods and compositions for diagnosis of glioblastoma or a subtype thereof." This patent discloses an isoform-level gene panel that can accurately classify a glioblastoma subtype from a tumor sample. The gene panel comprises 121 to 214 target isoforms, which are essential for the accurate diagnosis of glioblastoma. Additionally, the patent includes reagents for quantitatively detecting the expression or activity of these target isoforms in patient samples. The assay employs algorithms and a novel computer program, facilitating high-throughput diagnostics.

Career Highlights

Throughout his career, Davuluri has worked with prestigious institutions, including The Wistar Institute of Anatomy & Biology and the University of Pennsylvania. His experience in these organizations has allowed him to develop innovative diagnostic methods that have the potential to improve patient outcomes.

Collaborations

Some of his notable coworkers include Sharmistha Pal and Yingtao Bi. Their collaborative efforts have contributed to the advancement of research in the field of glioblastoma diagnostics.

Conclusion

Ramana V Davuluri's contributions to the field of medical diagnostics, particularly in glioblastoma classification, highlight the importance of innovation in healthcare. His patented methods and collaborations with esteemed institutions underscore his commitment to improving cancer diagnosis and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…